天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11973
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
Talastine 16188-61-7
UCM-13207 1621536-10-4
(R)-AZD 9639 1646857-28-4
Isolupalbigenin 162616-70-8
AC 7739 162705-22-8
JG-231 1627126-59-3
Karavilagenin F 1639024-15-9
Aprutumab 1634620-63-5
BTA-9881 1646857-24-0
UniPR129 1639159-47-9
Delmetacin 16401-80-2
Inotuzumab 1660159-36-3
GBT1118 1628799-51-8
Zilovertamab 1643432-38-5
Leramistat 1642602-54-7
Itacnosertib 1628870-27-8
CRT-0105950 1661845-86-8
TL4-12 1620820-12-3
Ralaniten triacetate 1637573-04-6
Ranevetmab 1632282-27-9
Tavolixizumab 1635395-25-3
Honokiol DCA 1620160-42-0
Gü2602 1627094-88-5
(Rac)-Telinavir 162679-88-1
MAO-B-IN-8 1638956-60-1
GNE-8505 1620573-48-9
KZR-504 1629052-78-3
TASP0390325 1642187-96-9
(R)-DNMDP 1630760-60-9
Ladiratuzumab 1629760-28-6
TDRL-551 1644626-43-6
Zectivimod 1623066-63-6
SLMP53-1 1643469-17-3
HTL14242 1644645-32-8
pan-HER-IN-2 1639040-95-1
Nerelimomab 162774-06-3
Dapson-13C12 1632119-29-9
NDB 1660153-08-1
Selicrelumab 1622140-49-1
ZEN-3694 1643947-30-1
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride 162045-54-7
Rivabazumab 1627519-84-9
Suptavumab 1629615-23-1
Lupartumab 1640971-88-5
Relatlimab 1673516-98-7
PW0464 1643462-93-4
Azido-PEG3-C6-Cl 1625717-44-3
L-372662 162045-26-3
VU0453379 1638646-27-1
PDK1-IN-RS2 1643958-89-7
Timigutuzumab 1665274-14-5
Nav1.8-IN-4 1620846-16-3
DA-6886 1645260-76-9
Glycopyrronium tosylate 1624259-25-1
GPR81 agonist 1 1620992-67-7
GS-626510 1637770-13-8
Laprituximab 1622327-38-1
Frovocimab 1643672-70-1
DI-82 1638148-50-1
Osimertinib-d6 1638281-44-3
CT-2584 166981-13-1
ACT-660602 1646267-59-5
DHODH-IN-17 16344-26-6
ABI-1968 1626364-18-8
Vobarilizumab 1628814-88-9
URAT1 inhibitor 7 1632002-28-8
FD-IN-1 1646682-14-5
Gimsilumab 1648796-29-5
CPL304110 1627826-19-0
RS1-PDK1 inhibitor 1643958-85-3
Elsubrutinib 1643570-24-4
Fremanezumab 1655501-53-3
Eptinezumab 1644539-04-7
Cipepofol 1637741-58-2
BDBM50597431 1629853-49-1
Dalzanemdor 1629853-48-0
Ibiglustat succinate 1629063-80-4
TGP-377/421 16752-89-9
FGFR4-IN-5 1628793-01-0
BrBzGCp2 166038-00-2
Clivatuzumab 1622075-09-5
Fluoroethylnormemantine 1639210-26-6
(Rac)-Naxifylline 166181-76-6
Parthenosin 166196-16-3
Talviraline 163451-80-7
Navicixizumab 1638338-43-8
Otilimab 1638332-55-4
Enrasentan 167256-08-8
ALDH2 modulator 1 1629615-99-1
Fluoroethylnormemantine hydrochloride 1639210-25-5
Tomuzotuximab 1646321-00-7
Suvratoxumab 1629620-18-3
Flotetuzumab 1664355-28-5
Vonlerolizumab 1638935-72-4
Naratuximab 1622327-39-2
AGN 192870 166977-57-7
(Rac)-MEM 1003 165187-25-7
MLK-IN-1 1627729-62-7
hTYR/AbTYR-IN-1 1625821-37-5
TAK-020 1627603-21-7
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.